SAFETY, TOLERABILITY, AND PHARMACOKINETIC EFFECTS OF ELAFIBRANOR COADMINISTRATION WITH SIMVASTATIN: AN OPEN-LABEL PHASE I TRIAL

Authors
Category Primary study
ConferenceHepatology
Year 2023
This article has no abstract
Epistemonikos ID: d89d53f99d9a45c4773be54518c99861fb605bd6
First added on: Apr 30, 2026